GNLK.OB: Summary for GENELINK INC - Yahoo! Canada Finance

MORE ON GNLK.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

GENELINK INC (OTC BB:GNLK.OB) Delayed quote data

Last Trade:	0.13 USD
Trade Time:	Feb 9
Change:	0.01 (7.14%)
Prev Close:	0.14
Open:	0.14
Bid:	0.13 x 5000
Ask:	0.14 x 5000
1y Target Est:	N/A

Day's Range:	0.13 - 0.14
52wk Range:	0.06 - 0.56
Volume:	114,164
Avg Vol (3m):	576,280
Market Cap:	14.39M
P/E (ttm):	N/A
EPS (ttm):	-0.03
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add GNLK.OB to Portfolio

Download Data

HEADLINES

•	GENELINK INC Financials
	EDGAR Online Financials (Sat, Feb 6)

•	GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Mon, Feb 1)

•	GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
	EDGAR Online (Mon, Dec 28)

•	David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
	PRNewswire (Mon, Dec 28)

•	GeneLink Reports Third Quarter Results
	Business Wire (Mon, Nov 16)

•	GENELINK INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	GENELINK INC Files SEC form 10-K/A, Annual Report
	EDGAR Online (Thu, Nov 5)

•	GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Mon, Oct 5)

•	GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Wed, Aug 19)

•	GENELINK INC Files SEC form 8-K, Other Events
	EDGAR Online (Thu, Aug 13)

More Headlines for GNLK.OB...

BUSINESS SUMMARY

GeneLink, Inc., together with its subsidiary, Dermagenetics, Inc., operates as a biosciences company that creates genetic tests as the basis for personalized health, beauty, and wellness applications.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

GeneLink Inc. (GNLK.OB)